The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
Open accessAbstract
Seven patients with advanced multiple myeloma, refractory to therapy with alkylating agent-VAD (vincristine-adriamycin-dexamethasone), received a regimen combining high-dose melphalan with total body irradiation supported by autologous bone marrow transplantation. Very rapid, usually greater than 90% tumor mass reduction was achieved in six patients, regardless of prior chemotherapy responsiveness and marrow plasmacytosis up to 30%. Despite signs of early relapse in three patients (median remission duration of all patients, 15 months), five remain alive and well without further cytotoxic therapy from 2 to 21 months (median, 9+ months). Two patients died, one from surgical complications after transplantation and a second due to persistent neutropenia with fatal pneumonia. This treatment provides meaningful disease control for selected patients with resistant myeloma and a poor prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
Barlogie, B., Smith, L., & Alexanian, R. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405243102104 · Cited by 641
Self-citationHIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMA
MCELWAIN, T. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90739-0 · Cited by 510
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma
Barlogie, B., Hall, R., Zander, A., Dicke, K., & Alexanian, R. (1986) · Blood · doi:10.1182/blood.v67.5.1298.1298 · Cited by 340
Self-citationHigh-Dose Glucocorticoid Treatment of Resistant Myeloma
ALEXANIAN, R., BARLOGIE, B., & DIXON, D. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-1-8 · Cited by 248
Self-citationThe growth fraction of human myeloma cells
Drewinko, B., Alexanian, R., Boyer, H., Barlogie, B., & Rubinow, S. (1981) · Blood · doi:10.1182/blood.v57.2.333.333 · Cited by 141
Self-citationCytoplasmic immunoglobulin content in multiple myeloma.
Barlogie, B., Alexanian, R., Pershouse, M. A., Smallwood, L., & Smith, L. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112033 · Cited by 72
Self-citationMarrow cytometry and prognosis in myeloma.
Barlogie, B., Alexanian, R., Gehan, E. A., Smallwood, L., Smith, T., & Drewinko, B. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111056 · Cited by 48
Self-citation
Cited by
Attal, M., Harousseau, J.-L., Stoppa, A.-M., Sotto, J.-J., Fuzibet, J.-G., Rossi, J.-F., Casassus, P., Maisonneuve, H., Facon, T., Ifrah, N., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607113350204 · Cited by 2,548
Kyle, R. A., & Rajkumar, S. V. (2008) · Blood · doi:10.1182/blood-2007-10-078022 · Cited by 855
Raab, M. S., Podar, K., Breitkreutz, I., Richardson, P. G., & Anderson, K. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60221-x · Cited by 697
Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma
Barlogie, B., Jagannath, S., Desikan, K. R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., et al. (1999) · Blood · doi:10.1182/blood.v93.1.55.401k04_55_65 · Cited by 502
Self-citationTotal Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma
Barlogie, B., Jagannath, S., Desikan, K. R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., et al. (1999) · Blood · doi:10.1182/blood.v93.1.55 · Cited by 472
Self-citation
Metadata
- Authors
- Barlogie, B., Alexanian, R., Dicke, K., Zagars, G., Spitzer, G., Jagannath, S., & Horwitz, L.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1987-09-01
- Volume
- 70
- Issue
- 3
- Pages
- 869-872
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W195783192
- Cited by
- 273
- References
- 7
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. https://app.cochat.ai/papers/10.1182/blood.v70.3.869.869
- The paper
- Barlogie, B., Alexanian, R., Dicke, K., Zagars, G., Spitzer, G., Jagannath, S., & Horwitz, L. (1987). High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood. https://doi.org/10.1182/blood.v70.3.869.869
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.